Monitoring HPVrelated cervical precancers in Oregon Sean Schafer

  • Slides: 26
Download presentation
Monitoring HPVrelated cervical precancers in Oregon Sean Schafer, MD HIV/STD/TB Program Office of Disease

Monitoring HPVrelated cervical precancers in Oregon Sean Schafer, MD HIV/STD/TB Program Office of Disease Prevention Oregon State Public Health

I’m going to tell you… 1 2 3 In Portland since HPV vaccine introduction,

I’m going to tell you… 1 2 3 In Portland since HPV vaccine introduction, the number of …. Paps smears done Pre-cancers diagnosed… have declined The number of … Cervical pre-cancers occurring… might have declined Proportions of HPV types found in Portland precancers have changed

Papillomaviruses • Diverse • skin, mucous membranes • Cottontail rabbit wart, 1933 • Species

Papillomaviruses • Diverse • skin, mucous membranes • Cottontail rabbit wart, 1933 • Species specific

Papillomaviruses • >100 types • Non-oncogenic (6, 11) • Oncogenic (16, 18, 45, 31,

Papillomaviruses • >100 types • Non-oncogenic (6, 11) • Oncogenic (16, 18, 45, 31, 33, 35, 52, 58, 51, 56, 59, 39, 68, [66])

A 7 A 9

A 7 A 9

Lowry DR, Schiler JT. Prophylactic human papillomavirus vaccines. J Clin Inv. 2006; 116(5)

Lowry DR, Schiler JT. Prophylactic human papillomavirus vaccines. J Clin Inv. 2006; 116(5)

Lowry DR, Schiler JT. Prophylactic human papillomavirus vaccines. J Clin Inv. 2006; 116(5)

Lowry DR, Schiler JT. Prophylactic human papillomavirus vaccines. J Clin Inv. 2006; 116(5)

Lowry DR, Schiler JT. Prophylactic human papillomavirus vaccines. J Clin Inv. 2006; 116(5)

Lowry DR, Schiler JT. Prophylactic human papillomavirus vaccines. J Clin Inv. 2006; 116(5)

Monitoring HPV-related CIN 2+, Portland

Monitoring HPV-related CIN 2+, Portland

Cervical Dysplasia Surveillance Methods • Case definition – 18 years of age or older

Cervical Dysplasia Surveillance Methods • Case definition – 18 years of age or older – Reside in 28 -zip-code area in Portland metro area – Biopsy confirmed Cervical Intraepithelial Neoplasia (CIN) 2, CIN 3, CIN 2/3, Adenocarcinoma -in-situ (AIS) • Data – Pathology report – Demographics – from lab or provider – HPV vaccine history – from ALERT or provider • Specimens for HPV typing 10

Oregon’s Surveillance Area Columbia River Portland Metropolitan Area: Oregon

Oregon’s Surveillance Area Columbia River Portland Metropolitan Area: Oregon

HPV Monitoring Objectives • Incidence of high-grade cervical dysplasia (precancers, “CIN 2+”) • Prevalence

HPV Monitoring Objectives • Incidence of high-grade cervical dysplasia (precancers, “CIN 2+”) • Prevalence and distribution of HPV types

Incidence (per 100, 000) 250 CIN 2+ Diagnoses, Portland, OR, Ages 18– 21 y,

Incidence (per 100, 000) 250 CIN 2+ Diagnoses, Portland, OR, Ages 18– 21 y, by Year 2008– 2014 200 150 100 50 0 2008 2009 2010 2011 2012 2013 2014

History of American Cancer Society Cervical Cancer Screening Guidelines Pap Conventional or liquid Pap

History of American Cancer Society Cervical Cancer Screening Guidelines Pap Conventional or liquid Pap Yearly, every 3 years if consecutive negative Yearly, “less frequent” if 3 consecutive negative Yearly if conventional Pap, every 2 years if liquid Pap Every 3 years (21– 29) ≥ 20 y or upon first vaginal intercourse ≥ 18 y or upon first vaginal intercourse 3 y after first vaginal intercourse 21 y Pap Part of regular checkup None Pap (21– 29) Pap plus HPV test (30 – 65) None 1980 None 1987 Every 5 years (30– 65) 70 y if 3 consecutive neg. 2002 65 y 2012

CIN 2+ Incidence and Proportion of Women Aged 18– 20 y with ≥ 1

CIN 2+ Incidence and Proportion of Women Aged 18– 20 y with ≥ 1 Pap by Year, Portland OR, 2008– 2014 200 25 Incidence Screening Rate 150 15 100 10 50 5 0 0 2008 2009 2010 2011 2012 2013 2014 15 20 Screening Rate (%) Incidence (per 100, 000) 250

CIN 2+ Incidence and Proportion of Women Aged 21– 29 y with ≥ 1

CIN 2+ Incidence and Proportion of Women Aged 21– 29 y with ≥ 1 Pap by Year, Portland OR, 2008– 2014 40 Incidence Screening Rate 500 30 400 300 20 200 10 100 0 0 2008 2009 2010 2011 2012 2013 2014 16 Screening Rate (%) Incidence (per 100, 000) 600

CIN 2+ Incidence and Proportion of Women Aged 30– 39 y with ≥ 1

CIN 2+ Incidence and Proportion of Women Aged 30– 39 y with ≥ 1 Pap by Year, Portland OR, 2008– 2014 40 Incidence Screening Rate 300 30 20 100 10 0 0 2008 17 2009 2010 2011 2012 2013 2014 Screening Rate (%) Incidence (per 100, 000) 400

I’m going to tell you… 1 2 3 In Portland since HPV vaccine introduction,

I’m going to tell you… 1 2 3 In Portland since HPV vaccine introduction, the number of …. Paps smears done Pre-cancers diagnosed… have declined The number of … Cervical pre-cancers occurring… might have declined Proportions of HPV types found in Portland precancers have changed

HPV Typing by Age Group, CIN 2+, Portland 2008– 2016 N=1728 806 665 No

HPV Typing by Age Group, CIN 2+, Portland 2008– 2016 N=1728 806 665 No HPV Vaccines 203 31 9 18– 20 14 21– 29 Age Group 30– 39 ≥ 1 HPV Vaccine

HPV Types, CIN 2+, Portland Oregon, 2008– 2016 600 N=1728 Count 400 200 16

HPV Types, CIN 2+, Portland Oregon, 2008– 2016 600 N=1728 Count 400 200 16 18 31 33 35 39 45 45 52 53 56 58 59 6 66 68 70 73 82 IS 39 HPV Type

Gardasil Cervarix (HPV 6, 11, 16, 18) (HPV 16, 18) 2006 2009 Gardasil 9

Gardasil Cervarix (HPV 6, 11, 16, 18) (HPV 16, 18) 2006 2009 Gardasil 9 (HPV 6, 11, 16, 18, 33, 31, 45, 51, 58) 2014

HPV Types, CIN 2+, Portland Oregon, 2008– 2016 YES Percent Vaccinated NO 16, 18

HPV Types, CIN 2+, Portland Oregon, 2008– 2016 YES Percent Vaccinated NO 16, 18 33, 31, 45, 51, 58 HPV GROUPS All Others

HPV Types, CIN 2+ Cases in Women Aged <30 years, By Year, Portland, OR,

HPV Types, CIN 2+ Cases in Women Aged <30 years, By Year, Portland, OR, 2008– 2014 60 HPV Groups: 16, 18 33, 31, 45, 51 58 All other types Pct 40 2008 2009 2010 2011 Year 2012 2013 2014

HPV Types, CIN 2+ Cases in Women Aged <30 years, Portland, OR, by Race,

HPV Types, CIN 2+ Cases in Women Aged <30 years, Portland, OR, by Race, 2008– 2016 NH White NH Black Hispanic Other/Unk 50 Pct 40 20 10 0 16, 18 33, 31, 45, 51, 58 All other

I told you… 1 2 3 In Portland since HPV vaccine introduction, the number

I told you… 1 2 3 In Portland since HPV vaccine introduction, the number of …. Paps smears done Pre-cancers diagnosed… have declined The number of … Cervical pre-cancers occurring… might have declined Proportions of HPV types found in Portland precancers have changed